For definitions of the terms “fraud” and “similar fault” refer to GN 04105.005B.

The Group II exception for FSF applies when a prior favorable determination or decision was obtained by FSF. If we find that any prior favorable or partially favorable decision was obtained by FSF, we may find that the beneficiary or recipient is not disabled. In addition, we may reopen the prior determination on the remaining evidence.

At the time of a CDR, if the adjudicator discovers potential FSF was involved in a prior favorable determination or decision, the adjudicator must follow the FSF referral policy and procedures, see DI 23025.015. The adjudicator must complete appropriate FSF development and referral procedures before making the determination that the Group II FSF applies.

If there is not a previous referral or report from the Office of Inspector General (OIG) or the Cooperative Disability Investigations Unit (CDIU) for the prior determination or decision in question, the adjudicator must complete a referral through the Allegation Referral Intake System (ARIS), see DI 23025.010B.2.

This exception does not apply when FSF is involved only in the pending CDR. In this situation; follow the FSF instructions in DI 23025.000. When FSF occurs in the pending CDR, disregard evidence obtained by FSF and make a determination on the remaining evidence. This may result in either a cessation or a continuance determination.

References

•  

  DI 23025.000 Fraud or Similar Fault

•  

  DI 23027.000 Disability Determination Services (DDS) - Fraud and Similar Fault (FSF) Redeterminations

•  

  DI 27505.015 Fraud or Similar Fault - Reopenings

Failure to cooperate (FTC) means the beneficiary or recipient failed to comply with the request for evidence or action without good cause. For a definition of FTC, see DI 28075.005B.

If the beneficiary or recipient provides good cause for not cooperating, give the individual another opportunity to provide the needed evidence or perform the needed action. FTC without good cause is a basis for the Disability Determinations Services (DDS) to find a cessation and terminate Title II and/or Title XVI benefits only when there is not enough evidence in file to justify a continuance. FTC does not apply if there is enough evidence to make a continuance determination. For good cause reasons for FTC, see DI 28075.005F.1.

Children are not ordinarily in a position to pursue their claims independently. Make special efforts in Title XVI child cases involving noncooperation to identify and contact another adult or agency responsible for the child's care.

The general approach to apply FTC for CDRs is located in DI 28075.005. The references cited below provide a more detailed overview of the FTC process that applies to CDRs as well as initial claims. Field office (FO) instructions can be found in DI 13015.001 through DI 13015.025.

References

• •

  DI 23007.000 Failure to Cooperate - Table of Contents

• •

  DI 25205.020 Failure to Cooperate and Insufficient Evidence in Title XVI Disabled Child (DC) Cases

WU status exists when there is a question that needs to be resolved about whether the beneficiary or recipient continues to be disabled and the individual cannot be located at the last known address. If the DDS identifies the WU exception applies, the disability examiner stops development and returns the case to the FO as a "No Determination."

References

• •

  DI 13015.025B Field Office (FO) Assistance in Medical Continuing Disability Reviews (CDR) and Failure to Cooperate-Insufficient Evidence Decision (FTC) or Whereabouts Unknown (WU)

• •

  DI 28075.007 Whereabouts Unknown (WU) During a Medical Continuing Disability Review (CDR)

An individual must follow their own medical source’s prescribed treatment to receive disability, SSI, or statutory blindness benefits if the treatment is expected to:

• •

  restore the ability to engage in SGA in adult claim,

• •

  reduce functional limitations so that they are no longer marked and severe in child claims, or

• •

  restore vision in blindness claims.

  However, we do not require the individual to follow the prescribed treatment if they show good cause. For good cause reasons for failing to follow prescribed treatment see, DI 23010.011C.

References

• •

  DI 23010.006 Failure to Follow Prescribed Treatment (FTFPT) - General

• •

  DI 23010.007D When to Apply Failure to Follow Prescribed Treatment (FTFPT) Policy